Real-time enrollment status for this acne vulgaris clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 4:34 PM UTC
| NCT Number | NCT07863193 |
| Recruiting Status | Recruiting |
| Condition | Acne Vulgaris |
| Phase | PHASE3 |
| Target Enrollment | 800 participants |
| Active Locations | 4 sites in the US |
| Sponsor | Sagimet Biosciences Inc. |
| Last Updated on CT.gov | October 7, 2026 (5 days ago) |
As of October 12, 2026: Clinical trial NCT07863193 is currently recruiting participants. This phase3 study for acne vulgaris is actively seeking new participants at 4 locations across the United States. The study is sponsored by Sagimet Biosciences Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07863193 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 4 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07863193 was last updated 5 days ago (October 7, 2026). HelloStudys verifies this status automatically.